Six Reasons Drug Prices Are So High in the U.S.news2024-01-17T18:53:05+00:00January 17th, 2024|The New York Times|
El Paxlovid reduce el riesgo de muerte por covid, pero no todos los que lo necesitan lo tomannews2024-01-06T00:00:08+00:00January 6th, 2024|The New York Times|
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canadanews2024-01-05T18:06:59+00:00January 5th, 2024|The New York Times|
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.news2024-01-04T17:15:07+00:00January 4th, 2024|The New York Times|
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatmentsnews2023-12-19T08:01:00+00:00December 19th, 2023|The New York Times|
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Mostnews2023-12-08T22:46:17+00:00December 8th, 2023|The New York Times|
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.news2023-11-10T10:03:01+00:00November 10th, 2023|The New York Times|
Ending TB Is Within Reach — So Why Are Millions Still Dying?news2023-11-06T10:00:50+00:00November 6th, 2023|The New York Times|
FDA Issues Warning Over Misuse of Ketamine Therapynews2023-10-11T20:50:31+00:00October 11th, 2023|The New York Times|
